Author(s): Bhambar Kunal V, Bhambar Rajendra S., Darekar Avinash B., Gadakh Pravin P., Aher Rutuja

Email(s): kunalbhambar@gmail.com

DOI: 10.52711/0974-360X.2022.00930   

Address: Bhambar Kunal V1*, Bhambar Rajendra S.2, Darekar Avinash B3., Gadakh Pravin P.4, Aher Rutuja5
1MGV’s Pharmacy College, Panchavati, Nashik, Maharashtra, India.
2MGV’s Pharmacy College, Panchavati, Nashik, Maharashtra, India.
3KVN Naik SPS Institute of Pharmaceutical Education and Research, Canada Corner
Nashik.
4MGV’s Pharmacy College, Panchavati, Nashik, Maharashtra, India.
5Modern College of Pharmacy, Dehu Alandi Road Borhadewadi, Moshi, Pune.
*Corresponding Author

Published In:   Volume - 15,      Issue - 12,     Year - 2022


ABSTRACT:
Background: Oxaceprol is an anti-inflammatory and antirheumatic agent. Buccal route has advantage over conventional mode of drug administration. It avoids hepatic first pass metabolism and improve patient compliance. The main objective of the present study is to formulate and evaluation of buccal patches of Oxaceprol to overcome drawbacks of conventional dosage forms. Buccal patches were prepared by solvent-casting method using HPMC K-15 and PEG as plasticizer. Oxaceprol was initially characterized for its preliminary studies such as organoleptic properties, melting point, solubility, UV Spectroscopy, and FTIR studies. Drug-excipients compatibility was confirmed by FTIR, DSC and assay of drug content. The formulations were prepared and evaluated for parameters like physical appearance, thickness, weight uniformity, % moisture loss, folding endurance, drug content uniformity. All prepared patches of drug were smooth and elegant in appearance. No visible cracks were observed. All formulations were uniform in weight, thickness, and drug content. The folding endurance was increased with an increased in polymer concentration. In vitro drug release of F6 batch was 93.78% at the end 8 hr. Oxaceprol buccal patches showed enhanced the bioavailability. Release exponent n value obtained from Kors Meyer- Peppa’s equation was within 0.5 -1.0 which indicates anomalous release.


Cite this article:
Bhambar Kunal V, Bhambar Rajendra S., Darekar Avinash B., Gadakh Pravin P., Aher Rutuja. Formulation and Characterization of Buccal Patches of Oxaceprol. Research Journal of Pharmacy and Technology2022; 15(12):5512-6. doi: 10.52711/0974-360X.2022.00930

Cite(Electronic):
Bhambar Kunal V, Bhambar Rajendra S., Darekar Avinash B., Gadakh Pravin P., Aher Rutuja. Formulation and Characterization of Buccal Patches of Oxaceprol. Research Journal of Pharmacy and Technology2022; 15(12):5512-6. doi: 10.52711/0974-360X.2022.00930   Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-12-24


REFERANCES:
1.    Raghavendra Rao NG, Shravani B, Mettu Srikanth R, Overview on Buccal Drug Delivery Systems, Journal of Pharmaceutical Science & Research Vol.5(4), 2013, 80 – 88.
2.    Shalini Mishra, Kumar G., Kothiyal P., The Pharma Innovation, A review article: Recent Approaches in Buccal patches 2012,1(7):78-86.
3.    Patel, J.G., Ravat H.D., Patel, K.N., et al, Formulation and Evaluation of Mouth Dissolving Film of Domperidone, International Journal for Pharmaceutical Research Scholars,1(2), 2012, 244-253 .
4.    Jagdale Swati C., Hable Asawaree A., Kuchekar Bhanudas S., et al, Development and Evaluation of Mucoadhesive Buccal Patches of Nifedipine. Research Journal of Pharmacy and Technology 4(6): June 2011; Page 944-948.
5.    Adhikari SN, Nayak BS, Nayak AK et al, Formulation and evaluation of buccal patches for delivery of atenolol. AAPS Pharm Sci Tech. 2010;11(3):1038-1044. doi:10.1208/s12249-010-9459-z
6.    Salehi S, Boddohi S. New formulation and approach for mucoadhesive buccal film of rizatriptan benzoate. Prog Biomater. 2017 Dec;6(4):175-187. doi: 10.1007/s40204-017-0077-7.    
7.    Gu J, Chen N, Ding G, Zhang Z. Determination of oxaceprol in rat plasma by LC-MS/MS and its application in a pharmacokinetic study. Journal of Pharmaceutical Biomedical Analysis, 2011 Jan 5;54(1):173-8. doi: 10.1016/j.jpba.2010.08.011.
8.    Ionac M, Parnham MJ, Plauchithiu M, Brune K. Oxaceprol, an atypical inhibitor of inflammation and joint damage. Pharmacological research, 1996 Jun;33(6):367-73. doi: 10.1006/phrs.1996.0051.
9.    Peeush S., Gajendra S., Formulation and Evaluation of Buccal Patches of Terbutaline Sulphate. International Journal of Research in Pharmaceutical Sciences, 2010, 1(4), 440-449.
10.    Hassan M.A., Barakat N.S, EI-Badry M., Shetata S. M., Formulation and in vitro/in vivo evaluation of naproxen mucoadhesive buccal patches for local effect, Journal of Drug Delivery Science and Technology, 2011,21(5);423-431.
11.    Krishnarth N, Verma N, Basant S, Formulation and evaluation of mucoadhesive   buccal patches for delivery of Atenolol, International Journal of Pharmacy,2014,4(3):166-170.
12.    Kumara Swamy S., Shobha Rani S., Development, In-Vitro and Ex-Vivo Evaluation of Muco-adhesive Buccal patches of Candesartan Cilexetil. Research Journal of Pharmacy and Technology, 2019; 12(6): 3038-3044. doi:10.5958/0974-360X.2019.00514.6
13.    Maheswara Reddy D., C. Madhusudhana Chetty, Y. Dastagiri Reddy, et al. Formulation and Evaluation of Fast Dissolving Buccal Patches of Tenofovir Disoproxil Fumarate. Research Journal of Pharmacy and Technology, 2021; 14(1):225-230. doi: 10.5958/0974-360X.2021.00039.1
14.    Krishna R., Juveria T. Formulation and Evaluation of Bioadhesive Buccal Drug Delivery of Sumatriptan Succinate Tablets. Asian Journal of Pharmaceutical Research, 2020; 10(2):105-109. doi: 10.5958/2231-5691.2020.00020.9
15.    Jhansipriya M., Dinesh P.,Chitosan Based Sustained Release Mucoadhesive Buccal Patches Containing Amlodipine Besylate (AMB). Asian Journal of Pharmaceutical Research, 2017; 7(2): 97-104. doi: 10.5958/2231-5659.2017.00015.7
16.    Rajesh Kumar. D, Vinod Kumar. K, Buccal Patches-A Review. Research Journal Pharmaceutical Dosage Form and Technology 6(3): July- Sept. 2014; 167-173.
17.    Puja S., Pratik S., Formulation Development and Evaluation of Buccal Patches of Aceclofenac for Gingivitis, Research Journal Pharmaceutical Dosage Form and Technology, 2017; 9(4): 163-167.
18.    Jagdale Swati C., Hable Asawaree A., Kuchekar Bhanudas S., et al, Development and Evaluation of Mucoadhesive Buccal Patches of Nifedipine. Research Journal of Pharmacy and Technology, 4(6): June 2011; 944-948.
19.    Kumara Swamy S., Shobha Rani S., et al Development, In-Vitro and Ex-Vivo Evaluation of Muco-adhesive Buccal patches of Candesartan cilexetil. Research Journal of Pharmacy and Technology, 2019; 12(6): 3038-3044.
20.    D. Maheswara Reddy, C. Madhusudhana Chetty, Y. Dastagiri Reddy, et al. Formulation and Evaluation of Fast Dissolving Buccal Patches of Tenofovir Disoproxil Fumarate. Research Journal of Pharmacy and Technology,2021; 14(1):225-230.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available